Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Thermal coagulation induced by high-intensity focused ultrasound is a therapeutic procedure where high-energy ultrasonic waves are focused into deep tissues. The acoustic energy is absorbed by body tissues and converted into heat, resulting in localized temperatures (typically above 60°C) that cause protein denaturation, coagulation necrosis, and tissue ablation. The technology is widely used for noninvasive or minimally invasive ablation of tumors, control of bleeding, and destruction of benign or malignant tissues. Unlike molecular drug targets, this approach exploits physical energy delivery rather than specific biochemical interactions, and therapeutic selectivity is determined by imaging guidance and energy focusing rather than molecular binding.
Thermal coagulation (focused ultrasound beam raises tissue temperature, denatures proteins, causes coagulative necrosis and vessel sealing)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Thermal coagulation induced by high-intensity focused ultrasound (HIFU-induced thermal coagulation).